Sfoglia per Autore
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors.
2008-01-01 Poggi, G; Quaretti, P; Minoia, C; Bernardo, G; Regazzi Bonora, M; Gaggeri, RAFFAELLA FRANCESCA; Ronchi, A; Massa Saluzzo, C; Azzaretti, A; Rodolico, G; Montagna, B; Amatu, A; Teragni, C; Palumbo, I; Traverso, E; Tonini, S; Villani, L; Scelsi, M; Paola Baiardi, P; Felisi, Mg; Sottotetti, F; Riccardi, Alberto
Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE)
2009-01-01 Sottani, C.; Leoni, E.; Porro, B.; Montagna, B.; Amatu, A.; Sottotetti, F.; Quaretti, P.; Poggi, G.; Minoia, C.
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
2009-01-01 Poggi, G; Amatu, A; Montagna, B; Quaretti, P; Minoia, C; Sottani, C; Villani, L; Tagliaferri, B; Sottotetti, F; Rossi, O; Pozzi, E; Zappoli, F; Riccardi, Alberto; Bernardo, G.
Treatment of chronic hepatitis C in a patient affected by systemic sclerosis
2009-01-01 Poggi, G.; Villani, L.; Sottotetti, F.; Tagliaferri, B.; Montagna, B.; Amatu, A.; Bernardo, G.
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.
2010-01-01 Poggi, G; Pozzi, E; Riccardi, Alberto; Tonini, S; Montagna, B; Quaretti, P; Tagliaferri, B; Sottotetti, F; Baiardi, P; Pagella, C; Minoia, C; Bernardo, G.
Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization
2011-01-01 Poggi, G.; Quaretti, P.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Amatu, A.; Pagella, C.; Bernardo, G.
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials.
2012-01-01 Strada, M. R.; Palumbo, R.; Bernardo, A.; Riccardi, Alberto; Teragni, C.; Poggi, G.; Frascaroli, M.; Amatu, A.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Bernardo, G.
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.
2012-01-01 Strada, Mr; Palumbo, R; Bernardo, A; Riccardi, Alberto; Teragni, C; Poggi, G; Frascaroli, M; Amatu, A; Montagna, B; Sottotetti, F; Tagliaferri, B; Bernardo, G.
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians
2013-01-01 Palumbo, R; Sottotetti, F; Riccardi, Alberto; Teragni, C; Pozzi, E; Quaquarini, E; Tagliaferri, B; Bernardo, A.
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life
2015-01-01 Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A.
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients?
2016-01-01 Palumbo, R.; Sottotetti, F.; Bernardo, A.
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant
2016-01-01 Del Re, M.; Quaquarini, E.; Sottotetti, F.; Michelucci, A.; Palumbo, R.; Simi, P.; Danesi, R.; Bernardo, A.
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study
2017-01-01 Lambertini, M.; Ferreira, A. R.; Di Meglio, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Bernardo, A.; Risi, E.; Dellepiane, C.; Sini, V.; Minuti, G.; Grasso, D.; Fancelli, S.; Del Mastro, L.
Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients
2017-01-01 Quaquarini, E.; Sottotetti, F.; D'Ambrosio, D.; Malovini, A.; Morganti, S.; Marinello, A.; Pavesi, L.; Frascaroli, M.
Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
2018-01-01 Broccoli, A.; Casadei, B.; Morigi, A.; Sottotetti, F.; Gotti, M.; Spina, M.; Volpetti, S.; Ferrero, S.; Spina, F.; Pisani, F.; Merli, M.; Visco, C.; Paolini, R.; Zilioli, V. R.; Baldini, L.; Di Renzo, N.; Tosi, P.; Cascavilla, N.; Molica, S.; Ilariucci, F.; Rigolin, G. M.; D'Alo, F.; Vanazzi, A.; Santambrogio, E.; Marasca, R.; Mastrullo, L.; Castellino, C.; Desabbata, G.; Scortechini, I.; Trentin, L.; Morello, L.; Argnani, L.; Zinzani, P. L.
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series
2018-01-01 Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A.
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
2018-01-01 Martel, S.; Poletto, E.; Ferreira, A. R.; Lambertini, M.; Sottotetti, F.; Bertolini, I.; Montemurro, F.; Bernardo, A.; Risi, E.; Zanardi, E.; Ziliani, S.; Mura, S.; Dellepiane, C.; Del Mastro, L.; Minisini, A. M.; Puglisi, F.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience
2019-01-01 Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A.
Palbociclib in metastatic breast cancer: Current evidence and real-life data
2019-01-01 Serra, F.; Lapidari, P.; Quaquarini, E.; Tagliaferri, B.; Sottotetti, F.; Palumbo, R.
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
2019-01-01 Quaquarini, Erica; D'Ambrosio, D.; Sottotetti, Federico; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, Rosalia; Vellani, C.; Canevari, C.; Bernardo, A.; Castiglioni, I.; Porta, C.; Trifiro, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. | 1-gen-2008 | Poggi, G; Quaretti, P; Minoia, C; Bernardo, G; Regazzi Bonora, M; Gaggeri, RAFFAELLA FRANCESCA; Ronchi, A; Massa Saluzzo, C; Azzaretti, A; Rodolico, G; Montagna, B; Amatu, A; Teragni, C; Palumbo, I; Traverso, E; Tonini, S; Villani, L; Scelsi, M; Paola Baiardi, P; Felisi, Mg; Sottotetti, F; Riccardi, Alberto | |
| Validation of an LC-MS/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE) | 1-gen-2009 | Sottani, C.; Leoni, E.; Porro, B.; Montagna, B.; Amatu, A.; Sottotetti, F.; Quaretti, P.; Poggi, G.; Minoia, C. | |
| OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. | 1-gen-2009 | Poggi, G; Amatu, A; Montagna, B; Quaretti, P; Minoia, C; Sottani, C; Villani, L; Tagliaferri, B; Sottotetti, F; Rossi, O; Pozzi, E; Zappoli, F; Riccardi, Alberto; Bernardo, G. | |
| Treatment of chronic hepatitis C in a patient affected by systemic sclerosis | 1-gen-2009 | Poggi, G.; Villani, L.; Sottotetti, F.; Tagliaferri, B.; Montagna, B.; Amatu, A.; Bernardo, G. | |
| Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. | 1-gen-2010 | Poggi, G; Pozzi, E; Riccardi, Alberto; Tonini, S; Montagna, B; Quaretti, P; Tagliaferri, B; Sottotetti, F; Baiardi, P; Pagella, C; Minoia, C; Bernardo, G. | |
| Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization | 1-gen-2011 | Poggi, G.; Quaretti, P.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Amatu, A.; Pagella, C.; Bernardo, G. | |
| Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. | 1-gen-2012 | Strada, M. R.; Palumbo, R.; Bernardo, A.; Riccardi, Alberto; Teragni, C.; Poggi, G.; Frascaroli, M.; Amatu, A.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Bernardo, G. | |
| Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. | 1-gen-2012 | Strada, Mr; Palumbo, R; Bernardo, A; Riccardi, Alberto; Teragni, C; Poggi, G; Frascaroli, M; Amatu, A; Montagna, B; Sottotetti, F; Tagliaferri, B; Bernardo, G. | |
| Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians | 1-gen-2013 | Palumbo, R; Sottotetti, F; Riccardi, Alberto; Teragni, C; Pozzi, E; Quaquarini, E; Tagliaferri, B; Bernardo, A. | |
| Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life | 1-gen-2015 | Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A. | |
| Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients? | 1-gen-2016 | Palumbo, R.; Sottotetti, F.; Bernardo, A. | |
| Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant | 1-gen-2016 | Del Re, M.; Quaquarini, E.; Sottotetti, F.; Michelucci, A.; Palumbo, R.; Simi, P.; Danesi, R.; Bernardo, A. | |
| Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study | 1-gen-2017 | Lambertini, M.; Ferreira, A. R.; Di Meglio, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Bernardo, A.; Risi, E.; Dellepiane, C.; Sini, V.; Minuti, G.; Grasso, D.; Fancelli, S.; Del Mastro, L. | |
| Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients | 1-gen-2017 | Quaquarini, E.; Sottotetti, F.; D'Ambrosio, D.; Malovini, A.; Morganti, S.; Marinello, A.; Pavesi, L.; Frascaroli, M. | |
| Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma | 1-gen-2018 | Broccoli, A.; Casadei, B.; Morigi, A.; Sottotetti, F.; Gotti, M.; Spina, M.; Volpetti, S.; Ferrero, S.; Spina, F.; Pisani, F.; Merli, M.; Visco, C.; Paolini, R.; Zilioli, V. R.; Baldini, L.; Di Renzo, N.; Tosi, P.; Cascavilla, N.; Molica, S.; Ilariucci, F.; Rigolin, G. M.; D'Alo, F.; Vanazzi, A.; Santambrogio, E.; Marasca, R.; Mastrullo, L.; Castellino, C.; Desabbata, G.; Scortechini, I.; Trentin, L.; Morello, L.; Argnani, L.; Zinzani, P. L. | |
| Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series | 1-gen-2018 | Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A. | |
| Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer | 1-gen-2018 | Martel, S.; Poletto, E.; Ferreira, A. R.; Lambertini, M.; Sottotetti, F.; Bertolini, I.; Montemurro, F.; Bernardo, A.; Risi, E.; Zanardi, E.; Ziliani, S.; Mura, S.; Dellepiane, C.; Del Mastro, L.; Minisini, A. M.; Puglisi, F. | |
| Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience | 1-gen-2019 | Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A. | |
| Palbociclib in metastatic breast cancer: Current evidence and real-life data | 1-gen-2019 | Serra, F.; Lapidari, P.; Quaquarini, E.; Tagliaferri, B.; Sottotetti, F.; Palumbo, R. | |
| Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel | 1-gen-2019 | Quaquarini, Erica; D'Ambrosio, D.; Sottotetti, Federico; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, Rosalia; Vellani, C.; Canevari, C.; Bernardo, A.; Castiglioni, I.; Porta, C.; Trifiro, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile